Atomic AI (Series A)

Funding Details
Date Award
January 25, 2023
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
Atomic AI is an emerging biotechnology company exploiting the cutting-edge fusion of artificial intelligence and structural biology to unlock RNA drug discovery. Based on research prominently featured in Science, Atomic AI's proprietary R&D platform leverages state-of-the-art deep learning foundation models integrated into a virtuous cycle with purpose-designed, in-house wet-lab assays, to discover and design proprietary 3D RNA structural datasets.
Market
RNA drug discovery
Coinvestors
8VC, AME Cloud Ventures, Doug Mohr, FactoryHQ, Greylock, Nat Friedman, Neal Khosla, Not Boring Capital, Patrick Hsu, Playground Global

Links
Back to Home Back to Biotechnology Deals View Funding Announcement